Wyeth advances synthesis of dual selective serotonin reuptake inhibitors/5-HT1A antagonists Sep. 4, 2008
Refinement of H3 receptor antagonists for wakefulness continues at Arena Pharmaceuticals Sep. 4, 2008
Pain Therapeutics receives USD 20,000,000 in milestone payments from King Pharmaceuticals Sep. 3, 2008
RSS